These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 21182834)
1. Akt2 and nucleophosmin/B23 function as an oncogenic unit in human lung cancer cells. Kim CK; Nguyen TL; Lee SB; Park SB; Lee KH; Cho SW; Ahn JY Exp Cell Res; 2011 Apr; 317(7):966-75. PubMed ID: 21182834 [TBL] [Abstract][Full Text] [Related]
2. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699 [TBL] [Abstract][Full Text] [Related]
3. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs. Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic role of nucleophosmin/B23. Yung BY Chang Gung Med J; 2007; 30(4):285-93. PubMed ID: 17939258 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193 [TBL] [Abstract][Full Text] [Related]
6. Akt2 is implicated in skeletal muscle differentiation and specifically binds Prohibitin2/REA. Héron-Milhavet L; Mamaeva D; Rochat A; Lamb NJ; Fernandez A J Cell Physiol; 2008 Jan; 214(1):158-65. PubMed ID: 17565718 [TBL] [Abstract][Full Text] [Related]
7. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells. Yeh CW; Huang SS; Lee RP; Yung BY Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. Sithanandam G; Fornwald LW; Fields J; Anderson LM Oncogene; 2005 Mar; 24(11):1847-59. PubMed ID: 15688028 [TBL] [Abstract][Full Text] [Related]
9. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway. Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813 [TBL] [Abstract][Full Text] [Related]
10. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration. Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells. Han EK; Mcgonigal T; Butler C; Giranda VL; Luo Y Anticancer Res; 2008; 28(2A):957-63. PubMed ID: 18507042 [TBL] [Abstract][Full Text] [Related]
12. Involvement of nucleophosmin/B23 in the cellular response to curcumin. Weng CH; Yung BY; Weng JJ; Wu MH J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727 [TBL] [Abstract][Full Text] [Related]
13. Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells. Hara S; Nakashiro K; Goda H; Hamakawa H Biochem Biophys Res Commun; 2008 May; 370(1):123-8. PubMed ID: 18355439 [TBL] [Abstract][Full Text] [Related]
14. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189 [TBL] [Abstract][Full Text] [Related]
15. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells. Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239 [TBL] [Abstract][Full Text] [Related]
16. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Li J; Chen Y; Zhao J; Kong F; Zhang Y Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697 [TBL] [Abstract][Full Text] [Related]
17. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits Akt-mediated oncogenic transformation and tumor growth. Liu X; Powlas J; Shi Y; Oleksijew AX; Shoemaker AR; De Jong R; Oltersdorf T; Giranda VL; Luo Y Anticancer Res; 2004; 24(5A):2697-704. PubMed ID: 15517874 [TBL] [Abstract][Full Text] [Related]
19. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744 [TBL] [Abstract][Full Text] [Related]
20. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling. Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]